Lance armstrong and bill clinton help fred baron get tysabri
Fred Baron, a well-known lawyer with late-stage multiple myeloma, will be treated with multiple sclerosis drug Tysabri after all, AP reports this morning.
We first learned of Baron’s saga yesterday, when WSJ’s Law Blog reported that Baron’s doctors at Mayo Clinic wanted to treat him with drug, but Biogen Idec, which [...]
Computing with RNA
Devices that self-assemble from biological molecules could represent future of drug delivery.
SHARETHIS.addEntry({ title: “Computing with RNA”, url: “http://techhairball.com/wp/2008/10/17/computing-with-rna/” });
Sphere: Related Content
Genentech’s earnings show why companies want cancer drugs
Courtesy of Genentech’s third quarter earnings, here are three reasons why every drug company under sun wants to get into biotech business and develop more cancer treatments:
Avastin sales, up 18% to $704 million
Rituxan sales, up 15% to $655 million
Herceptin sales, up 15% to $368 million
Numbers like those ( increases are year-over-year) are also [...]
More ways for aging stem cells to go awry
re closer scientists look, more ways y find for our aging stem cells to fail. Since stem cells are necessary to repair ongoing wear in our tissues, ir loss of function is an important contributer to degenerative aging. My attention was drawn today to a novel discovery: a malfunction in mechanisms of cell [...]
Direct results of mitochondrial dna damage
As regular readers already know, damage to your mitochondrial DNA is important to aging process. It is first step in a chain of events that leads to dysfunctional mitochondria, damaged tissues, and processes run awry in body. You might want to follow that link and read introduction if this is new [...]
Baldness Genes
Finding genetic causes could lead to new rapies for baldness.
SHARETHIS.addEntry({ title: “Baldness Genes”, url: “http://techhairball.com/wp/2008/10/13/baldness-genes/” });
Sphere: Related Content
Presented By: IBM Web Conferencing – Complimentary 14 Day Trial
Run better meetings online with Lotus Sametime Unyte.
No downloads, no training – and no need to call IT for help.
Click to start your complimentary 14-day trial today.
Ads by Pheedo
SHARETHIS.addEntry({ title: “Presented By: IBM Web Conferencing – Complimentary 14 Day Trial”, url: “http://techhairball.com/wp/2008/10/13/presented-by-ibm-web-conferencing-%e2%80%93-complimentary-14-day-trial/” });
Sphere: Related Content
Imclone vs. gm — no contest on market capitalization
Here’s an unreality check to give some perspective of carnage on Wall Street: market cap of biotech upstart ImClone Systems is nearly double that of General Motors.
ImClone, company whose insider trading scandal made Martha Stewart infamous, is trading today around $65 a share. Don’t hold us to precise numbers in trading this [...]
Palau ‘n’ jak3
Palau’s got Jak3: WO/2008/119792, purines for Jak3: WO/2008/090181 too. From sound of ir pipeline DP1’s in re somewhere.
Posted in biotech, JAK (Source: KinasePro)
SHARETHIS.addEntry({ title: “Palau ‘n’ jak3″, url: “http://techhairball.com/wp/2008/10/12/palau-%e2%80%98n%e2%80%99-jak3/” });
Sphere: Related Content
Attacking Cancer Stem Cells
A screening approach identifies drugs that halt cells that feed tumors.
SHARETHIS.addEntry({ title: “Attacking Cancer Stem Cells”, url: “http://techhairball.com/wp/2008/10/08/attacking-cancer-stem-cells/” });
Sphere: Related Content
Bristol-myers loses imclone but gains $1 billion
Bristol-Myers Squibb lost out on acquiring ImClone today when Eli Lilly swooped in with a higher bid. But Bristol has come out of this thing looking pretty good.
Bristol already owned about 17% of ImClone when it bid $60 per share for rest of company at end of July. That was a meaty premium [...]
Genentech study failure highlights pitfalls of cancer drug combos
Combining two targeted lung cancer drugs — Avastin and Tarceva — didn’t extend lives any more than giving patients Tarceva alone, Genentech said. (Genentech sells Avastin in U.S., and it co-markets Tarceva with OSI Pharmaceuticals.)
Researchers have been struggling for a while now to find effective combinations of targeted cancer medicines that every drug [...]
$5000 complete gene sequencing in 2q 2009
Our biotechnological future is coming even faster than I expected. A Mountain View California biotech start-up, Complete Genomics, operating in stealth mode since a 2006 founding, has announced availability of… (Source: FuturePundit)
SHARETHIS.addEntry({ title: “$5000 complete gene sequencing in 2q 2009″, url: “http://techhairball.com/wp/2008/10/08/5000-complete-gene-sequencing-in-2q-2009/” });
Sphere: Related Content
$5000 complete gene sequencing in 2q 2009
Our biotechnological future is coming even faster than I expected. A Mountain View California biotech start-up, Complete Genomics, operating in stealth mode since a 2006 founding, has announced availability of… (Source: FuturePundit)
SHARETHIS.addEntry({ title: “$5000 complete gene sequencing in 2q 2009″, url: “http://techhairball.com/wp/2008/10/08/5000-complete-gene-sequencing-in-2q-2009/” });
Sphere: Related Content
What financial crisis? eli lilly buying imclone for $6.5 billion
Never mind credit crunch. Pharma companies are sitting on cash, and y’re desperate to get into biotech business. Eli Lilly said this morning that it has agreed to buy ImClone for $70 a share in a deal worth $6.5 billion.
An ImClone statement this morning was basically a platform for ImClone chairman Carl Icahn [...]